These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9538140)
1. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro. Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786 [TBL] [Abstract][Full Text] [Related]
3. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15. Uchiyama-Kokubu N; Watanabe T; Cohen D Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863 [TBL] [Abstract][Full Text] [Related]
4. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833. Jiang XR; Kelsey SM; Wu YL; Newland AC Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760 [TBL] [Abstract][Full Text] [Related]
6. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Lopes EC; Scolnik M; Alvarez E; Hajos SE Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565 [TBL] [Abstract][Full Text] [Related]
7. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment. Jetté L; Murphy GF; Béliveau R Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Pilarski LM; Yatscoff RW; Murphy GF; Belch AR Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608 [TBL] [Abstract][Full Text] [Related]
9. Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers. Didier A; Wenger J; Loor F Anticancer Drugs; 1995 Oct; 6(5):669-80. PubMed ID: 8845477 [TBL] [Abstract][Full Text] [Related]
10. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110 [TBL] [Abstract][Full Text] [Related]
11. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226 [TBL] [Abstract][Full Text] [Related]
12. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Drach J; Gsur A; Hamilton G; Zhao S; Angerler J; Fiegl M; Zojer N; Raderer M; Haberl I; Andreeff M; Huber H Blood; 1996 Sep; 88(5):1747-54. PubMed ID: 8781431 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250 [TBL] [Abstract][Full Text] [Related]
14. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128 [TBL] [Abstract][Full Text] [Related]
15. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3. Ernest S; Bello-Reuss E Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674 [TBL] [Abstract][Full Text] [Related]
16. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein. Kusunoki N; Takara K; Tanigawara Y; Yamauchi A; Ueda K; Komada F; Ku Y; Kuroda Y; Saitoh Y; Okumura K Jpn J Cancer Res; 1998 Nov; 89(11):1220-8. PubMed ID: 9914792 [TBL] [Abstract][Full Text] [Related]
18. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia. Grey M; Borg AG; Wood P; Burgess R; Fisher A; Yin JA Leuk Res; 1997 Sep; 21(9):867-74. PubMed ID: 9393602 [TBL] [Abstract][Full Text] [Related]
19. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo. Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]